Trial Profile
A randomized, open-label study of the effect of CellCept, sirolimus, and corticosteroids with or without daclizumab on the pharmacokinetics of mycophenolic acid in renal transplant patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2010
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Ciclosporin; Corticosteroids; Daclizumab; Sirolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Roche
- 26 Feb 2010 New trial record